238 related articles for article (PubMed ID: 21955045)
1. Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in mice.
Wu Y; Lousberg EL; Moldenhauer LM; Hayball JD; Coller JK; Rice KC; Watkins LR; Somogyi AA; Hutchinson MR
Br J Pharmacol; 2012 Mar; 165(5):1319-29. PubMed ID: 21955045
[TBL] [Abstract][Full Text] [Related]
2. TLR4-MyD88 signalling: a molecular target for alcohol actions.
Pandey SC
Br J Pharmacol; 2012 Mar; 165(5):1316-8. PubMed ID: 21955082
[TBL] [Abstract][Full Text] [Related]
3. Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signaling.
Corrigan F; Wu Y; Tuke J; Coller JK; Rice KC; Diener KR; Hayball JD; Watkins LR; Somogyi AA; Hutchinson MR
Brain Behav Immun; 2015 Mar; 45():245-52. PubMed ID: 25542736
[TBL] [Abstract][Full Text] [Related]
4. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance.
Medvedev AE; Piao W; Shoenfelt J; Rhee SH; Chen H; Basu S; Wahl LM; Fenton MJ; Vogel SN
J Biol Chem; 2007 Jun; 282(22):16042-53. PubMed ID: 17392283
[TBL] [Abstract][Full Text] [Related]
5. Sedative and Motor Incoordination Effects of Ethanol in Mice Lacking CD14, TLR2, TLR4, or MyD88.
Blednov YA; Black M; Benavidez JM; Da Costa A; Mayfield J; Harris RA
Alcohol Clin Exp Res; 2017 Mar; 41(3):531-540. PubMed ID: 28160299
[TBL] [Abstract][Full Text] [Related]
6. Propofol Inhibits Lipopolysaccharide-Induced Inflammatory Responses in Spinal Astrocytes via the Toll-Like Receptor 4/MyD88-Dependent Nuclear Factor-κB, Extracellular Signal-Regulated Protein Kinases1/2, and p38 Mitogen-Activated Protein Kinase Pathways.
Zhou CH; Zhu YZ; Zhao PP; Xu CM; Zhang MX; Huang H; Li J; Liu L; Wu YQ
Anesth Analg; 2015 Jun; 120(6):1361-8. PubMed ID: 25695672
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide enhances decorin expression through the Toll-like receptor 4, myeloid differentiating factor 88, nuclear factor-kappa B, and mitogen-activated protein kinase pathways in odontoblast cells.
He W; Qu T; Yu Q; Wang Z; Wang H; Zhang J; Smith AJ
J Endod; 2012 Apr; 38(4):464-9. PubMed ID: 22414830
[TBL] [Abstract][Full Text] [Related]
8. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.
Byrd-Leifer CA; Block EF; Takeda K; Akira S; Ding A
Eur J Immunol; 2001 Aug; 31(8):2448-57. PubMed ID: 11500829
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production via down-regulation of MyD88 expression.
Noman AS; Koide N; Hassan F; I-E-Khuda I; Dagvadorj J; Tumurkhuu G; Islam S; Naiki Y; Yoshida T; Yokochi T
Innate Immun; 2009 Feb; 15(1):33-41. PubMed ID: 19201823
[TBL] [Abstract][Full Text] [Related]
10. Role and mechanism of esketamine in improving postoperative cognitive dysfunction in aged mice through the TLR4/MyD88/p38 MAPK pathway.
Xu HJ; Li XP; Han LY
Kaohsiung J Med Sci; 2024 Jan; 40(1):63-73. PubMed ID: 38018683
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with
Wang X; Han C; Qin J; Wei Y; Qian X; Bao Y; Shi W
J Interferon Cytokine Res; 2019 Aug; 39(8):495-505. PubMed ID: 31074668
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
[TBL] [Abstract][Full Text] [Related]
13. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
[TBL] [Abstract][Full Text] [Related]
15. 7-methoxyflavanone alleviates neuroinflammation in lipopolysaccharide-stimulated microglial cells by inhibiting TLR4/MyD88/MAPK signalling and activating the Nrf2/NQO-1 pathway.
Qu Z; Chen Y; Luo ZH; Shen XL; Hu YJ
J Pharm Pharmacol; 2020 Mar; 72(3):385-395. PubMed ID: 31867739
[TBL] [Abstract][Full Text] [Related]
16. Palmitate Activates CCL4 Expression in Human Monocytic Cells via TLR4/MyD88 Dependent Activation of NF-κB/MAPK/ PI3K Signaling Systems.
Kochumon S; Wilson A; Chandy B; Shenouda S; Tuomilehto J; Sindhu S; Ahmad R
Cell Physiol Biochem; 2018; 46(3):953-964. PubMed ID: 29669317
[TBL] [Abstract][Full Text] [Related]
17. Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-κB/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic.
Justino PFC; Franco AX; Pontier-Bres R; Monteiro CES; Barbosa ALR; Souza MHLP; Czerucka D; Soares PMG
Cytokine; 2020 Jan; 125():154791. PubMed ID: 31401369
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Li YF; Wang H; Fan Y; Shi HJ; Wang QM; Chen BR; Khurwolah MR; Long QQ; Wang SB; Wang ZM; Wang LS
Cell Physiol Biochem; 2017; 43(3):926-936. PubMed ID: 28957799
[TBL] [Abstract][Full Text] [Related]
19. The scaffold MyD88 acts to couple protein kinase Cepsilon to Toll-like receptors.
Faisal A; Saurin A; Gregory B; Foxwell B; Parker PJ
J Biol Chem; 2008 Jul; 283(27):18591-600. PubMed ID: 18458086
[TBL] [Abstract][Full Text] [Related]
20. Opioid activation of toll-like receptor 4 contributes to drug reinforcement.
Hutchinson MR; Northcutt AL; Hiranita T; Wang X; Lewis SS; Thomas J; van Steeg K; Kopajtic TA; Loram LC; Sfregola C; Galer E; Miles NE; Bland ST; Amat J; Rozeske RR; Maslanik T; Chapman TR; Strand KA; Fleshner M; Bachtell RK; Somogyi AA; Yin H; Katz JL; Rice KC; Maier SF; Watkins LR
J Neurosci; 2012 Aug; 32(33):11187-200. PubMed ID: 22895704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
